These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. New potential renin inhibitors with dipeptide replacements in the molecule. Winiecka I; Dudkiewicz-Wilczyńska J; Roman I; Paruszewski R Acta Pol Pharm; 2010; 67(4):367-74. PubMed ID: 20635532 [TBL] [Abstract][Full Text] [Related]
5. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions. Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of porcine pepsin by two substrate analogues containing statine. The effect of histidine at the P2 subsite on the inhibition of aspartic proteinases. Maibaum J; Rich DH J Med Chem; 1988 Mar; 31(3):625-9. PubMed ID: 3126296 [TBL] [Abstract][Full Text] [Related]
11. Interaction of mouse submaxillary gland renin with a statine-containing, subnanomolar, competitive inhibitor. Poe M; Perlow DS; Boger J J Enzyme Inhib; 1985; 1(1):13-23. PubMed ID: 3916910 [TBL] [Abstract][Full Text] [Related]
12. New renin inhibitors with pseudodipeptidic units in P(1)-P(1') and P(2')-P(3') positions. Paruszewski R; Jaworski P; Winiecka I; Tautt J; Dudkiewicz J Chem Pharm Bull (Tokyo); 2002 Jun; 50(6):850-3. PubMed ID: 12045347 [TBL] [Abstract][Full Text] [Related]
13. Metabolic profile of a peptide-conjugated chlorin-type photosensitizer targeting neuropilin-1: an in vivo and in vitro study. Tirand L; Thomas N; Dodeller M; Dumas D; Frochot C; Maunit B; Guillemin F; Barberi-Heyob M Drug Metab Dispos; 2007 May; 35(5):806-13. PubMed ID: 17283031 [TBL] [Abstract][Full Text] [Related]
14. A continuous fluorescence assay of renin activity. Wang GT; Chung CC; Holzman TF; Krafft GA Anal Biochem; 1993 May; 210(2):351-9. PubMed ID: 8512070 [TBL] [Abstract][Full Text] [Related]
15. Peptide inhibitors of renin in cardiovascular studies. Haber E Fed Proc; 1983 Dec; 42(15):3155-61. PubMed ID: 6196232 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of cathepsin D by substrate analogues containing statine and by analogues of pepstatin. Agarwal NS; Rich DH J Med Chem; 1986 Dec; 29(12):2519-24. PubMed ID: 3783611 [TBL] [Abstract][Full Text] [Related]
17. Design of potent substrate-analogue inhibitors of canine renin. Hui KY; Siragy HM; Haber E Int J Pept Protein Res; 1992 Aug; 40(2):152-60. PubMed ID: 1446972 [TBL] [Abstract][Full Text] [Related]
18. Statine-containing dipeptide and tripeptide inhibitors of human renin. Kokubu T; Hiwada K; Nagae A; Murakami E; Morisawa Y; Yabe Y; Koike H; Iijima Y Hypertension; 1986 Jun; 8(6 Pt 2):II1-5. PubMed ID: 3087874 [TBL] [Abstract][Full Text] [Related]
19. The first Sir George Pickering memorial lecture. Which inhibitors will give us true insight into what renin really does? Haber E J Hypertens; 1984 Jun; 2(3):223-30. PubMed ID: 6099385 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and renin inhibitory activity of angiotensinogen analogues having dehydrostatine, Leu psi [CH2S]Val, or Leu psi [CH2SO]Val at the P1-P1' cleavage site. Smith CW; Saneii HH; Sawyer TK; Pals DT; Scahill TA; Kamdar BV; Lawson JA J Med Chem; 1988 Jul; 31(7):1377-82. PubMed ID: 3290486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]